DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,921,000 | +492.9% | 95,276 | +996.4% | 0.02% | +533.3% |
Q2 2021 | $324,000 | -90.8% | 8,690 | -93.7% | 0.00% | -91.2% |
Q1 2021 | $3,531,000 | +19.1% | 138,074 | +2.6% | 0.03% | +3.0% |
Q4 2020 | $2,965,000 | +73.6% | 134,585 | +41.7% | 0.03% | +32.0% |
Q3 2020 | $1,708,000 | -33.3% | 94,957 | -5.8% | 0.02% | -26.5% |
Q2 2020 | $2,561,000 | +12.1% | 100,837 | -18.9% | 0.03% | -2.9% |
Q1 2020 | $2,285,000 | -24.8% | 124,411 | -9.8% | 0.04% | +45.8% |
Q4 2019 | $3,038,000 | +55.2% | 137,919 | +1.2% | 0.02% | +60.0% |
Q3 2019 | $1,957,000 | -13.1% | 136,304 | -4.7% | 0.02% | -11.8% |
Q2 2019 | $2,252,000 | – | 143,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |